News
Abbott Secures CE Mark for Stool-Based Colorectal Cancer Screening Test
Abbott’s Cologuard Plus, developed in collaboration with Mayo Clinic, analyses multiple DNA markers and blood in the stool associated with colorectal cancer and advanced precancerous lesions.


